Concepedia

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)

Shujie Huang, Hansheng Wu, Chao Cheng, Ming Zhou, Enwu Xu, Wanli Lin, Guangsuo Wang, Jiming Tang, Xiaosong Ben, Dongkun Zhang,

Frontiers in Immunology · 2022 · 28 citations · 33 references

DOIFull text

Open access

Abstract

Our results supported that conversion surgery following immunochemotherapy is feasible and safe for patients with initially unresectable locally advanced ESCC. Both radiological and pathological response rates were significantly higher in the iIC cohort compared with those in the traditional iC cohort.

References

33

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 28.6K citations

, , +9

Cancer statistics in China, 2015

Wanqing Chen, Rongshou Zheng, Peter D. Baade et al. · CA A Cancer Journal for Clinicians · 2016 · 17.9K citations · Full text

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun, Lin Shen, Manish A. Shah et al. · The Lancet · 2021 · 1.5K citations · Full text

, , +8

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

New England Journal of Medicine · 2022 · 1.1K citations · Full text

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

Karen Becker, James Mueller, Christoph Schulmacher et al. · Cancer · 2003 · 800 citations · Full text

, , +18